Audien has quickly emerged as a category leader in the OTC hearing aid market by developing sleek, nearly invisible in-ear ...

Following completion of the dose escalation phase in relapsed/refractory acute leukemia patients with FLT3 mutations, Biomea ...

The Company is quickly advancing both its Marijuana Breath Test (MBT) with key validation work established in March, and its ...

Medical Advisory Board additions support company’s growing product offerings across women’s health and family building. NEW ...

Inozyme recently featured new clinical insights and hosted an educational symposium at the Joint Congress of the European ...

Explore NovaaLab’s FDA-cleared red light therapy devices, supported by clinical studies, and designed to help reduce pain, improve recovery, and support wellness — all from the comfort of home. Salt ...

Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received seven years of orphan-drug exclusive approval from U.S.

Sight Sciences’ management is scheduled to present on Tuesday, May 27, 2025, at 09:00 am PT / 12:00 pm ET. Interested parties may access a live and archived webcast of the fireside chat on the ...

SeaStar Medical Holding Corporation (Nasdaq: ICU) a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life ...

Goldberg will sit down with CNBC’s Tim Seymour on Wednesday, June 4, for an exclusive conversation in the Special Events Area on the CMB exhibit floor. The discussion will dive into the fast-rising ...

STRATA management will host a conference call at 5:00 p.m. ET on Wednesday, May 14, 2025 to review financial results and provide an update on corporate developments. Following management’s formal ...

Alumis received an upfront license fee of $20.0 million in March 2025 and will receive an additional $20.0 million in near-term co-development payments, with potential for additional milestone ...